TABLE 1. Outcome Table for Female Meditators and Controls.

			Baseline		After Treatment		Treatment-by-Time Effect, F
Variable	Condition	N	M	SD	M	SD		P	η p 2
Reaction timea
	Men	14	1448.4	727.3	1351.6	632.6
	MED	14	2134.1	856.8	1403.6	462.3	5.5	.03	0.16
	CON	16	1865.1	800.4	1893.6	780.6
Attention
MAAS–total	MED	12	3.8	0.5	4.3	0.5	13.2	.001	0.34
	CON	16	4.1	0.4	4.0	0.4
FFMQ–total	MED	12	123.5	13.8	139.9	11.8	13.0	.001	0.33
	CON	16	133.3	8.5	135.1	9.5
FFMQ–observe	MED	12	27.1	4.1	29.8	3.5	3.0	.09	0.10
	CON	16	27.6	3.9	28.0	5.0
FFMQ–describe	MED	12	26.9	5.7	29.4	5.8	6.9	.04	0.14
	CON	16	27.6	4.7	27.9	4.7
Self-judgment
FFMQ–nonjudge	MED	12	25.8	6.4	31.3	6.3	4.1	.05	0.14
	CON	16	28.1	4.6	29.8	3.8
SPWB–self-acceptance	MED	12	62.8	11.3	69.6	8.9	10.7	.003	0.29
	CON	16	65.2	10.6	63.9	8.3
Clinical/well-being
SPWB–well-being	MED	12	383.7	37.8	403.5	35.9	4.3	.04	0.14
	CON	16	380.9	42.5	380.4	36.8
BSI–depression	MED	12	4.6	4.1	2.6	3.3	4.0	.05	0.13
	CON	16	3.5	3.7	4.3	3.6
BSI–anxiety	MED	12	3.8	3.1	2.1	1.7	5.0	.03	0.16
	CON	16	4.4	2.9	4.8	2.6

M = mean; SD = standard deviation; MED = meditation condition; CON = control condition; MAAS = Mindful Attention Awareness Scale; FFMQ = Five Facet Mindfulness Questionnaire; SPWB = Scales of Psychological Well-being; BSI = Brief Symptom Inventory.

^aReaction time to sexual slides.